Maravai Lifesciences Holdings Inc (MRVI)
Healthcare
Biotechnology
6.60 $
-2.7%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Maravai Lifesciences Holdings Inc (MRVI)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 68.6% of the shares are freely tradable; institutional investors hold 88.5%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
88.5%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
13.9%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
68.6%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
7.0%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
148Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| GTCR LLC | 13.66 | 20,150,005 | +0.0 | 03/31/2026 |
| BRAIDWELL LP | 6.94 | 10,240,164 | +22.6 | 03/31/2026 |
| BlackRock Inc | 6.34 | 9,345,268 | -0.4 | 03/31/2026 |
| 12 West Capital Management LP | 4.92 | 7,260,195 | -18.6 | 03/31/2026 |
| Vanguard Group Inc | 4.86 | 7,166,528 | +0.6 | 12/31/2025 |
| Mackenzie Investments | 4.28 | 6,306,425 | +2.2 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.69 | 5,449,702 | +0.0 | 03/31/2026 |
| Renaissance Technologies Corp | 2.89 | 4,264,689 | +0.9 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Canada Life US Small-Mid Cap Growth F | 3.10 | 4,573,360 | +0.0 | 03/31/2026 |
| Vanguard Total Stock Mkt Idx Inv | 2.66 | 3,923,526 | +0.0 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.